These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 32393487)

  • 1. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides (Clostridium) difficile in adults with diarrhoea in Vietnam.
    Khun PA; Phi LD; Bui HTT; Collins DA; Riley TV
    Anaerobe; 2023 Jun; 81():102741. PubMed ID: 37244476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides (Clostridium) difficile in children with diarrhoea in Vietnam.
    Khun PA; Phi LD; Pham PT; Thu Nguyen HT; Huyen Vu QT; Collins DA; Riley TV
    Anaerobe; 2022 Apr; 74():102550. PubMed ID: 35331913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
    Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
    Tsai CS; Lu PL; Lu MC; Hsieh TC; Chen WT; Wang JT; Ko WC
    J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides (Clostridium) difficile isolated from paediatric patients in Western Australia 2019-2020.
    Perumalsamy S; Lim SC; Riley TV
    Pathology; 2022 Jun; 54(4):460-465. PubMed ID: 35125203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and Genomic Insights into
    Knight DR; Kullin B; Androga GO; Barbut F; Eckert C; Johnson S; Spigaglia P; Tateda K; Tsai PJ; Riley TV
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992351
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental contamination with Clostridioides (Clostridium) difficile in Vietnam.
    Khun PA; Phi LD; Bui HTT; Bui NT; Vu QTH; Trinh LD; Collins DA; Riley TV
    J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37296244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
    Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Collins DA; Sohn KM; Wu Y; Ouchi K; Ishii Y; Elliott B; Riley TV; Tateda K;
    Emerg Microbes Infect; 2020; 9(1):42-52. PubMed ID: 31873046
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial resistance in
    Imwattana K; Knight DR; Kullin B; Collins DA; Putsathit P; Kiratisin P; Riley TV
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):17-25. PubMed ID: 31800331
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.
    Knight DR; Riley TV
    J Antimicrob Chemother; 2016 Aug; 71(8):2213-7. PubMed ID: 27130808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.